E Capello

Summary

Affiliation: University of Genoa
Country: Italy

Publications

  1. ncbi request reprint Marburg type and Balò's concentric sclerosis: rare and acute variants of multiple sclerosis
    E Capello
    Deparment of Neuroscience, Oftalmology and Genetics, University of Genoa, Via De Toni 5, I 16132 Genoa, Italy
    Neurol Sci 25:S361-3. 2004
  2. ncbi request reprint Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis
    E Capello
    Department of Neurological Sciences Ophthalmology and Genetics, University of Genoa, Via De Toni 5, I 16132, Genoa, Italy
    Neurol Sci 26:S200-3. 2005
  3. doi request reprint Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience
    G L Mancardi
    Department of Neuroscience, Ophthalmology and Genetics, University of Genoa, Genoa, Italy
    Mult Scler 18:835-42. 2012
  4. ncbi request reprint Acute axonal form of Guillain-Barré syndrome in a multiple sclerosis patient: chance association or linked disorders?
    E Capello
    Department of Neurological Sciences and Vision, University of Genoa, Genoa, Italy
    Eur J Neurol 7:223-5. 2000
  5. ncbi request reprint Demyelination and axonal damage in a non-human primate model of multiple sclerosis
    G Mancardi
    Department of Neurological Sciences and Vision, University of Genoa, Via De Toni 5, 16132 Genoa, Italy
    J Neurol Sci 184:41-9. 2001
  6. ncbi request reprint Restricted immune responses lead to CNS demyelination and axonal damage
    G Mancardi
    Department of Neurological Sciences and Vision, University of Genova, Via De Toni 5, 16132, Genoa, Italy
    J Neuroimmunol 107:178-83. 2000
  7. doi request reprint Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks
    E Capello
    Department of Neuroscience, Ophthalmology and Genetics, University of Genova, Genoa, Italy
    Neurol Sci 30:S175-7. 2009
  8. ncbi request reprint Tumor-like multiple sclerosis (MS) lesions: neuropathological clues
    E Capello
    Department of Neurological Sciences and Vision, University of Genoa, Italy
    Neurol Sci 22:S113-6. 2001
  9. doi request reprint Association of melanoma and natalizumab therapy in the Italian MS population: a second case report
    A Laroni
    Multiple Sclerosis Center, Department of Neurosciences, Ophthalmology and Genetics, University of Genoa, Genoa, Italy
    Neurol Sci 32:181-2. 2011
  10. doi request reprint Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification
    A Laroni
    Department of Neuroscience, Ophthalmology and Genetics, University of Genova, Via De Toni 5, 16132, Genoa, Italy
    J Neuroimmune Pharmacol 7:665-72. 2012

Collaborators

Detail Information

Publications16

  1. ncbi request reprint Marburg type and Balò's concentric sclerosis: rare and acute variants of multiple sclerosis
    E Capello
    Deparment of Neuroscience, Oftalmology and Genetics, University of Genoa, Via De Toni 5, I 16132 Genoa, Italy
    Neurol Sci 25:S361-3. 2004
    ..Although in some patients a favourable clinical course has been described, the poor prognosis of the majority of these cases justifies a treatment with intense immunosuppression...
  2. ncbi request reprint Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis
    E Capello
    Department of Neurological Sciences Ophthalmology and Genetics, University of Genoa, Via De Toni 5, I 16132, Genoa, Italy
    Neurol Sci 26:S200-3. 2005
    ..These results support a role for intense immunosuppression followed by ASCT as treatment in rapidly evolving MS cases unresponsive to conventional therapies...
  3. doi request reprint Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience
    G L Mancardi
    Department of Neuroscience, Ophthalmology and Genetics, University of Genoa, Genoa, Italy
    Mult Scler 18:835-42. 2012
    ..The clinical outcome and the toxicity of AHSCT can be diverse, depending on the various types of conditioning protocols and on the disease phase...
  4. ncbi request reprint Acute axonal form of Guillain-Barré syndrome in a multiple sclerosis patient: chance association or linked disorders?
    E Capello
    Department of Neurological Sciences and Vision, University of Genoa, Genoa, Italy
    Eur J Neurol 7:223-5. 2000
    ..It remains unresolved if the association of an axonal form of GBS and MS is fortuitous or, on the contrary, is indicative of the coexistence in some individuals of common pathogenetic mechanisms...
  5. ncbi request reprint Demyelination and axonal damage in a non-human primate model of multiple sclerosis
    G Mancardi
    Department of Neurological Sciences and Vision, University of Genoa, Via De Toni 5, 16132 Genoa, Italy
    J Neurol Sci 184:41-9. 2001
    ..These findings are of relevance for the development of therapies, which can protect axons and enhance their function and survival...
  6. ncbi request reprint Restricted immune responses lead to CNS demyelination and axonal damage
    G Mancardi
    Department of Neurological Sciences and Vision, University of Genova, Via De Toni 5, 16132, Genoa, Italy
    J Neuroimmunol 107:178-83. 2000
    ....
  7. doi request reprint Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks
    E Capello
    Department of Neuroscience, Ophthalmology and Genetics, University of Genova, Genoa, Italy
    Neurol Sci 30:S175-7. 2009
    ..The risk of mortality, which dropped in the last years to 2-3%, is still the main problem of this powerful therapy...
  8. ncbi request reprint Tumor-like multiple sclerosis (MS) lesions: neuropathological clues
    E Capello
    Department of Neurological Sciences and Vision, University of Genoa, Italy
    Neurol Sci 22:S113-6. 2001
    ..These cases are characterized by a severe clinical course and a rapid clinical deterioration, only partially modified by medical treatments. Atypical severe cases, misdiagnosed as MS, can be indeed due to primary CNS vasculitis...
  9. doi request reprint Association of melanoma and natalizumab therapy in the Italian MS population: a second case report
    A Laroni
    Multiple Sclerosis Center, Department of Neurosciences, Ophthalmology and Genetics, University of Genoa, Genoa, Italy
    Neurol Sci 32:181-2. 2011
    ..Here we report a case of melanoma in a patient who developed melanoma after 77 infusions of natalizumab, without known risk factors. Pharmacovigilance programs of new drugs can help to monitor adverse events in patients at risk...
  10. doi request reprint Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification
    A Laroni
    Department of Neuroscience, Ophthalmology and Genetics, University of Genova, Via De Toni 5, 16132, Genoa, Italy
    J Neuroimmune Pharmacol 7:665-72. 2012
    ..In conclusion, testing JCV-DNA in urine is complementary to testing anti-JCV antibodies in identifying patients at risk of PML...
  11. ncbi request reprint EAE in the common marmoset Callithrix jacchus
    A Uccelli
    Neuroimmunology Unit, Department of Neurosciences, Ophthalmology and Genetics and Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy
    Int MS J 10:6-12. 2003
    ....
  12. ncbi request reprint Tremor associated with benign IgM paraproteinaemic neuropathy successfully treated with gabapentin
    A Saverino
    Department of Neurological Sciences and Vision, University of Genoa, Genoa, Italy
    Mov Disord 16:967-8. 2001
    ..The patient reached the full dose of 1,200 mg/day of gabapentin without side effects and showed a significant therapy-related improvement of tremor and disability, as judged by the Fahn Tolosa Marin Rating Scale...
  13. doi request reprint Activity, tolerability and efficacy of levetiracetam on cerebellar symptoms in multiple sclerosis patients: a pilot kinematic study
    C Solaro
    Center of Bioengineering, Hospital La Colletta, Arenzano, Italy
    Eur J Neurol 15:619-26. 2008
    ....
  14. ncbi request reprint The 14-3-3 protein in multiple sclerosis: a marker of disease severity
    M Colucci
    Department of Neuroscience, Ophthalmology and Genetic and Center of Excellence for Biomedical Research, University of Genova, Genova, Italy
    Mult Scler 10:477-81. 2004
    ..In multiple sclerosis (MS) axonal damage is an early event and is probably to be considered the most relevant cause of permanent and progressive disability...
  15. ncbi request reprint Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses
    M Rovaris
    Neuroimaging Research Unit, Department of Neuroscience, Scientific Institute and University Ospedale San Raffaele, Milan, Italy
    Neurology 59:1429-32. 2002
    ..GA is effective in reducing MS activity, independent of the severity of the MRI-detectable inflammatory process...
  16. ncbi request reprint Autologous stem cell transplantation for severe autoimmune diseases: a 10-year experience
    F Gualandi
    Division of Hematology and Stem Cell Transplantation Center, Azienda Ospedaliera Universitaria S Martino, Italy
    Ann N Y Acad Sci 1110:455-64. 2007
    ..The mechanism of action of this intervention remains not completely understood, as briefly discussed here...